Mukka Proteins Limited Announces Audited Financial Results for Q4FY26
Mukka Proteins Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results on May 15, 2026. The information was published in newspapers on May 16, 2026.
This is a standard disclosure of financial results, which is expected from listed companies and does not contain any new material information that would significantly impact the company's stock or operations.
The announcement is a routine disclosure of financial results and compliance with listing regulations, with no specific positive or negative financial performance indicators mentioned in the provided text.
Mukka Proteins Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results at a meeting held on May 15, 2026.
The company has made these results available on its website and the websites of the BSE and NSE. This announcement is in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and newspaper advertisements were published on May 16, 2026, in Business Standard (English) and Vijaya Karnataka (Kannada).
This is a routine disclosure of financial results and compliance with listing regulations.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.